183 related articles for article (PubMed ID: 23136979)
1. A nine-coordinated bismuth(III) complex derived from pentadentate 2,6-diacetylpyridine bis((4)N-methylthiosemicarbazone): crystal structure and both in vitro and in vivo biological evaluation.
Li MX; Yang M; Niu JY; Zhang LZ; Xie SQ
Inorg Chem; 2012 Nov; 51(22):12521-6. PubMed ID: 23136979
[TBL] [Abstract][Full Text] [Related]
2. One dodecahedral bismuth(III) complex derived from 2-acetylpyridine N(4)-pyridylthiosemicarbazone: synthesis, crystal structure and biological evaluation.
Li M; Lu Y; Yang M; Li Y; Zhang L; Xie S
Dalton Trans; 2012 Nov; 41(41):12882-7. PubMed ID: 22986888
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, crystal structure and biological evaluation of a main group seven-coordinated bismuth(III) complex with 2-acetylpyridine N4-phenylthiosemicarbazone.
Li YK; Yang M; Li MX; Yu H; Wu HC; Xie SQ
Bioorg Med Chem Lett; 2013 Apr; 23(8):2288-92. PubMed ID: 23489627
[TBL] [Abstract][Full Text] [Related]
4. Syntheses, crystal structures and antimicrobial activities of monomeric 8-coordinate, and dimeric and monomeric 7-coordinate bismuth(III) complexes with tridentate and pentadentate thiosemicarbazones and pentadentate semicarbazone ligands.
Nomiya K; Sekino K; Ishikawa M; Honda A; Yokoyama M; Chikaraishi Kasuga N; Yokoyama H; Nakano S; Onodera K
J Inorg Biochem; 2004 Apr; 98(4):601-15. PubMed ID: 15041240
[TBL] [Abstract][Full Text] [Related]
5. Coordination of thiosemicarbazones and bis(thiosemicarbazones) to bismuth(III) as a strategy for the design of metal-based antibacterial agents.
Lessa JA; Reis DC; Da Silva JG; Paradizzi LT; da Silva NF; Carvalho Mde F; Siqueira SA; Beraldo H
Chem Biodivers; 2012 Sep; 9(9):1955-66. PubMed ID: 22976983
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, crystal structures, in vitro biological evaluation of zinc(II) and bismuth(III) complexes of 2-acetylpyrazine N(4)-phenylthiosemicarbazone.
Li MX; Zhang LZ; Yang M; Niu JY; Zhou J
Bioorg Med Chem Lett; 2012 Apr; 22(7):2418-23. PubMed ID: 22401862
[TBL] [Abstract][Full Text] [Related]
7. Potent anticancer activity of a new bismuth (III) complex against human lung cancer cells.
Ouyang R; Yang Y; Tong X; Feng K; Yang Y; Tao H; Zhang X; Zong T; Cao P; Xiong F; Guo N; Li Y; Miao Y; Zhou S
J Inorg Biochem; 2017 Mar; 168():18-26. PubMed ID: 28006662
[TBL] [Abstract][Full Text] [Related]
8. Dual anticancer and antibacterial activities of bismuth compounds based on asymmetric [NN'O] ligands.
Marzano IM; Tomco D; Staples RJ; Lizarazo-Jaimes EH; Gomes DA; Bucciarelli-Rodriguez M; Guerra W; de Souza ÍP; Verani CN; Pereira Maia EC
J Inorg Biochem; 2021 Sep; 222():111522. PubMed ID: 34218087
[TBL] [Abstract][Full Text] [Related]
9. Making bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(III) acetylsalicylate.
Andrews PC; Blair VL; Ferrero RL; Junk PC; Kumar I
Chem Commun (Camb); 2013 Apr; 49(28):2870-2. PubMed ID: 23450139
[TBL] [Abstract][Full Text] [Related]
10. Main group bismuth(III), gallium(III) and diorganotin(IV) complexes derived from bis(2-acetylpyrazine)thiocarbonohydrazone: synthesis, crystal structures and biological evaluation.
Zhang N; Tai Y; Li M; Ma P; Zhao J; Niu J
Dalton Trans; 2014 Apr; 43(13):5182-9. PubMed ID: 24504550
[TBL] [Abstract][Full Text] [Related]
11. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and in vitro pharmacological evaluation of new water soluble Ni(II) complexes of 4N-substituted thiosemicarbazones of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde.
Ramachandran E; Senthil Raja D; Bhuvanesh NS; Natarajan K
Eur J Med Chem; 2013 Jun; 64():179-89. PubMed ID: 23644201
[TBL] [Abstract][Full Text] [Related]
13. Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes.
Ferraz KS; Silva NF; da Silva JG; de Miranda LF; Romeiro CF; Souza-Fagundes EM; Mendes IC; Beraldo H
Eur J Med Chem; 2012 Jul; 53():98-106. PubMed ID: 22520151
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, cytotoxicity and antimicrobial studies on bis(N-furfuryl-N-(2-phenylethyl)dithiocarbamato-S,S')zinc(II) and its nitrogen donor adducts.
Rani PJ; Thirumaran S
Eur J Med Chem; 2013 Apr; 62():139-47. PubMed ID: 23353751
[TBL] [Abstract][Full Text] [Related]
15. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
[TBL] [Abstract][Full Text] [Related]
16. Structures and biochemical evaluation of silver(I) 5,5-diethylbarbiturate complexes with bis(diphenylphosphino)alkanes as potential antimicrobial and anticancer agents.
Yilmaz VT; Icsel C; Batur J; Aydinlik S; Sahinturk P; Aygun M
Eur J Med Chem; 2017 Oct; 139():901-916. PubMed ID: 28881285
[TBL] [Abstract][Full Text] [Related]
17. Elaborated 1H NMR study for the ligitional behavior of two thiosemicarbazide derivatives towards some heavy metals (Sn(II), Sb(III), Pb(II) and Bi(III)), thermal, antibacterial and antifungal studies.
el-Metwaly NM; Refat MS
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):519-28. PubMed ID: 21767980
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a series of novel In(III) 2,6-diacetylpyridine bis(thiosemicarbazide) complexes: structure, anticancer function and mechanism.
Li S; Khan MH; Wang X; Cai M; Zhang J; Jiang M; Zhang Z; Wen XA; Liang H; Yang F
Dalton Trans; 2020 Dec; 49(47):17207-17220. PubMed ID: 33201167
[TBL] [Abstract][Full Text] [Related]
19. Role of substitution at terminal nitrogen of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde thiosemicarbazones on the coordination behavior and structure and biological properties of their palladium(II) complexes.
Ramachandran E; Senthil Raja D; Rath NP; Natarajan K
Inorg Chem; 2013 Feb; 52(3):1504-14. PubMed ID: 23323516
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.
Pathak A; Blair VL; Ferrero RL; Junk PC; Tabor RF; Andrews PC
Dalton Trans; 2015 Oct; 44(38):16903-13. PubMed ID: 26352159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
